The DOI matches its Crossref record.
Epidemiology of Hymenoptera allergy
Abstract
Purpose of review Epidemiology and especially the natural history of Hymenoptera allergy form the background that is essential to improving the clinical management of insect venom allergic patients. This review focuses on the emergence of recent data which could help provide further enlightenment in this field. Recent findings The latest data on the extent of the disease, the risk factors for sensitization and for local, systemic and fatal reactions after a hymenoptera sting are reviewed. The emerging problems concerning asymptomatic sensitization, the meaning of constitutively elevated tryptase serum levels and the persisting widespread poor awareness of available therapies in Hymenoptera allergic patients are particularly emphasized. Summary The assessment of the risk for systemic reaction in skin-positive subjects with a negative case history, and the suggestion of the baseline serum tryptase level as a risk factor for reaction severity after a sting, are the most important clinical implications of the latest studies. The genetic and environmental factors involved in the persistence of venom specific immunoglobulin E after a sting and the factors which orient towards a systemic or a large local reaction after apparently the same sting remain open questions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In considering this question, it should be noted that many people who develop type 2 immune responses to BV do not exhibit anaphylactic reactivity despite having venom-specific IgE antibodies [113].”
From Mast cells and IgE in defense against lethality of venoms: Possible “benefit” of allergy (2020) · cites this paper as [113]
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 35
- Charpin, 1994, Clin Exp Allergy, 24, 1010, 10.1111/j.1365-2222.1994.tb02736.x · DOI
- Kemp, 2000, J Allergy Clin Immunol, 105, 683, 10.1067/mai.2000.105707 · DOI
- Incorvaia, 1997, Allergy, 52, 680, 10.1111/j.1398-9995.1997.tb01056.x · DOI
- Charpin, 1992, J Allergy Clin Immunol, 90, 331, 10.1016/S0091-6749(05)80011-9 · DOI
- Kalyoncu, 1997, Ann Allergy Asthma Immunol, 78, 408, 10.1016/S1081-1206(10)63203-6 · DOI
- Bjornsson, 1995, Allergy, 50, 800, 10.1111/j.1398-9995.1995.tb05052.x · DOI
- Grigoreas, 1997, Allergy, 52, 51, 10.1111/j.1398-9995.1997.tb02545.x · DOI
- Bousquet, 1984, J Allergy Clin Immunol, 73, 332, 10.1016/0091-6749(84)90405-6 · DOI
- Novembre, 1998, Clin Exp Allergy, 28, 834, 10.1046/j.1365-2222.1998.00313.x · DOI
- Golden, 1997, J Allergy Clin Immunol, 100, 760, 10.1016/S0091-6749(97)70270-7 · DOI
- Pucci, 1994, Allergy, 49, 894, 10.1111/j.1398-9995.1994.tb00796.x · DOI
- Corry, 1999, Nature, 402, 18, 10.1038/35037014 · DOI
- Schafer, 1996, Allergy, 51, 372, 10.1111/j.1398-9995.1996.tb00144.x · DOI
- Hemmer, 2001, J Allergy Clin Immunol, 108, 1045, 10.1067/mai.2001.120013 · DOI
- Golden, 1989, JAMA, 262, 240, 10.1001/jama.1989.03430020082033 · DOI
- Annila, 1996, Ann Allergy Asthma Immunol, 77, 423, 10.1016/S1081-1206(10)63342-X · DOI
- Mauriello, 1984, J Allergy Clin Immunol, 74, 494, 10.1016/0091-6749(84)90384-1 · DOI
- Graft, 1984, J Pediatr, 104, 664, 10.1016/S0022-3476(84)80940-3 · DOI
- Jung, 1997, Allergy, 52, 717, 10.1111/j.1398-9995.1997.tb01228.x · DOI
- Klein, 1995, J Allergy Clin Immunol, 95, 637, 10.1016/S0091-6749(95)70329-2 · DOI
- Neugut, 2001, Arch Int Med, 16115-, 16121
- Yocum, 1999, J Allergy Clin Immunol, 104, 452, 10.1016/S0091-6749(99)70392-1 · DOI
- Stewart, 1996, Q J Med, 89, 859, 10.1093/qjmed/89.11.859 · DOI
- Brown, 2001, J Allergy Clin Immunol, 108, 861, 10.1067/mai.2001.119028 · DOI
- Pastorello, 2001, J Chromatogr B, 756, 11, 10.1016/S0378-4347(01)00067-6 · DOI
- Reisman, 1992, J Allergy Clin Immunol, 90, 335, 10.1016/S0091-6749(05)80012-0 · DOI
- Van der Linden, 1994, J Allergy Clin Immunol, 94, 151, 10.1053/ai.1994.v94.a54889 · DOI
- Golden, 2001, J Allergy Clin Immunol, 107, 897, 10.1067/mai.2001.114706 · DOI
- Fricker, 1997, J Allergy Clin Immunol, 100, 11, 10.1016/S0091-6749(97)70188-X · DOI
- Ludolph-Hauser, 2001, Lancet, 357, 361, 10.1016/S0140-6736(00)03647-3 · DOI
- Schwartz, 1988, Clin Allergy, 18, 461, 10.1111/j.1365-2222.1988.tb02896.x · DOI
- Oude Elberink, 1997, J Allergy Clin Immunol, 99, 153, 10.1016/S0091-6749(97)70314-2 · DOI
- Muller, 1991, Clin Exp Allergy, 21, 281, 10.1111/j.1365-2222.1991.tb01659.x · DOI
- Pumphrey, 2000, Clin Exp Allergy, 30, 1144, 10.1046/j.1365-2222.2000.00864.x · DOI
- McGain, 2000, Med J Aust, 173, 198, 10.5694/j.1326-5377.2000.tb125600.x · DOI
Cited by
Sorted by citations
EAACI Molecular Allergology User's Guide
Matricardi, P. M., Kleine‐Tebbe, J., Hoffmann, H. J., Valenta, R., Hilger, C., Hofmaier, S., Aalberse, R. C., Agache, I., Asero, R., Ballmer‐Weber, B., et al. (2016) · Pediatric Allergy and Immunology · doi:10.1111/pai.12563 · Cited by 932
Self-citationvan Anrooij, B., van der Veer, E., de Monchy, J. G. R., van der Heide, S., Kluin-Nelemans, J. C., van Voorst Vader, P. C., van Doormaal, J. J., & Oude Elberink, J. N. G. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.12.1578 · Cited by 89
Mast cells and IgE in defense against venoms: Possible “good side” of allergy?
Galli, S. J., Starkl, P., Marichal, T., & Tsai, M. (2016) · Allergology International · doi:10.1016/j.alit.2015.09.002 · Cited by 73
Mast cells and IgE in defense against lethality of venoms: Possible “benefit” of allergy
Galli, S. J., Metz, M., Starkl, P., Marichal, T., & Tsai, M. (2020) · Allergo Journal International · doi:10.1007/s40629-020-00118-6 · Cited by 57
Clonal mast cell disorders and hereditary α-tryptasemia as risk factors for anaphylaxis
Kačar, M., Rijavec, M., Šelb, J., & Korošec, P. (2023) · Clinical & Experimental Allergy · doi:10.1111/cea.14264 · Cited by 37
Metadata
- Authors
- Antonicelli, L., Bilò, M. B., & Bonifazi, F.
- Venue
- Current Opinion in Allergy and Clinical Immunology
- Published
- 2002-08
- Volume
- 2
- Issue
- 4
- Pages
- 341-346
- ISSN
- 1528-4050
- Cited by
- 147
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review